Obesity and prostate cancer
Related Experiment Video
Updated: Aug 20, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
1Division of Urologic Oncology, Department of Urology, Stanford University School of Medicine, Stanford, California 94305-5826, USA. jpresti@stanford.edu
Purpose Of Review:
This review provides an update on research into the association between obesity and prostate cancer.
Recent Findings:
The US Health Professional Study reported an inverse relationship between risk for prostate cancer and obesity in men under the age of 60 or in those with a positive family history for prostate cancer. Others found no association between obesity and risk for the disease. Regarding detection, obesity does not impact upon measurement of prostate specific antigen as a method of detecting prostate cancer; however, in a referral population there was an inverse association between detection rate and obesity. In three radical prostatectomy series, obesity was associated with worse pathological features and higher biochemical relapse rates. Possible mechanisms for the association between obesity and prostate cancer include the impact on serum testosterone, leptin, insulin-like growth factor I, and interleukin-6 levels.
Summary:
A growing body of evidence suggests that obesity may impact upon risk, detection and outcome with regard to prostate cancer.
Related Concept Videos
Obesity
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Psychoneuroimmunology: Diabetes and Cancer
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
